Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Adaptive Biotechnologies
(NASDAQ:ADPT)
Intraday
$2.60
-0.01
[-0.38%]
After-Hours
$2.60
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.60
-0.01
[-0.38%]
At close: Apr 26
$2.60
0
[0.00%]
After Hours: 7:16PM EDT
Get Report
Watch
Q1 2024 Earnings in 11 days from now on Tue May 7th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Adaptive Biotechnologies Stock (NASDAQ:ADPT)
Adaptive Biotechnologies Stock (NASDAQ: ADPT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 19, 2024
Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
-
Apr 19, 2024, 7:58AM
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 19, 2024, 5:45AM
Wednesday, April 17, 2024
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Apr 17, 2024, 1:36PM
Thursday, April 04, 2024
BTIG Maintains Buy on Adaptive Biotechnologies, Lowers Price Target to $5
Benzinga Newsdesk
-
Apr 4, 2024, 11:18AM
Wednesday, April 03, 2024
Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position
Vandana Singh
-
Apr 3, 2024, 1:42PM
Adaptive Biotechnologies shares are trading lower. The company yesterday provided a strategic review and announced preliminary Q1 2024 revenue.
Benzinga Newsdesk
-
Apr 3, 2024, 10:56AM
Tuesday, April 02, 2024
Adaptive Biotechnologies Provides Strategic Review Update And Announces Preliminary Q1 2024 Revenue Of $41M-$43M Vs $38.21M Est.
Benzinga Newsdesk
-
Apr 2, 2024, 4:12PM
Adaptive Biotechnologies Tycho Peterson, Chief Financial Officer Will Be Departing The Company To Pursue Another Opportunity. Kyle Piske Will Succeed Tycho As Full-time CFO
Benzinga Newsdesk
-
Apr 2, 2024, 4:11PM
Thursday, February 15, 2024
Adaptive Biotechnologies shares are trading lower after the company reported mixed Q4 financial results.
Benzinga Newsdesk
-
Feb 15, 2024, 8:41AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Feb 15, 2024, 8:05AM
Wednesday, February 14, 2024
Adaptive Biotechnologies shares are trading lower after the company reported mixed Q4 financial results.
Benzinga Newsdesk
-
Feb 14, 2024, 4:50PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Feb 14, 2024, 4:31PM
Adaptive Biotechnologies: Q4 Earnings Insights
Benzinga Insights
-
Feb 14, 2024, 4:30PM
Adaptive Biotechnologies Q4 2023 Adj EPS $(0.30) Beats $(0.33) Estimate, Sales $45.78M Miss $48.46M Estimate
Benzinga Newsdesk
-
Feb 14, 2024, 4:25PM
Earnings Scheduled For February 14, 2024
Benzinga Insights
-
Feb 14, 2024, 4:48AM
Tuesday, February 13, 2024
Earnings Preview For Adaptive Biotechnologies
Benzinga Insights
-
Feb 13, 2024, 12:01PM
Wednesday, December 13, 2023
Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam
Benzinga Neuro
-
Dec 12, 2023, 11:22PM
Monday, December 11, 2023
Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails
Benzinga Neuro
-
Dec 11, 2023, 10:55PM
Thursday, December 07, 2023
Cathie Wood's Ark Invest Trims Bitcoin Exposure, Sells $2.9M Worth Of GBTC Shares Amid Crypto Market Volatility
Benzinga Neuro
-
Dec 7, 2023, 10:10PM
Tuesday, December 05, 2023
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
Benzinga Newsdesk
-
Dec 5, 2023, 7:32AM
Tuesday, November 14, 2023
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Nov 14, 2023, 2:05PM
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Nov 14, 2023, 10:39AM
Monday, November 13, 2023
Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Lowers Price Target to $6
Benzinga Newsdesk
-
Nov 13, 2023, 4:08PM
Friday, November 10, 2023
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Nov 10, 2023, 1:34PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Nov 10, 2023, 12:31PM
Adaptive Biotechnologies shares are trading lower following worse-than-expected Q3 results.
Benzinga Newsdesk
-
Nov 10, 2023, 11:05AM
Thursday, November 09, 2023
Recap: Adaptive Biotechnologies Q3 Earnings
Benzinga Insights
-
Nov 9, 2023, 4:25PM
Adaptive Biotechnologies Q3 2023 EPS $(0.35) Misses $(0.34) Estimate, Revenue $37.9M Misses $42.963M Estimate
Benzinga Newsdesk
-
Nov 9, 2023, 4:09PM
Adaptive Biotechnologies Says Strategic Review Underway With Goldman Sachs
Benzinga Newsdesk
-
Nov 9, 2023, 4:08PM
Earnings Scheduled For November 9, 2023
Benzinga Insights
-
Nov 9, 2023, 6:52AM
Wednesday, November 08, 2023
Adaptive Biotechnologies's Earnings Outlook
Benzinga Insights
-
Nov 8, 2023, 11:01AM
Tuesday, November 07, 2023
Adaptive Biotechnologies Announces Collaboration With BeiGene To Measure Minimal Residual Disease With clonoSEQ Assay Across BeiGene's Lymphoid Malignancy Pipeline
Benzinga Newsdesk
-
Nov 7, 2023, 7:35AM
Tuesday, October 24, 2023
Expert Ratings for Adaptive Biotechnologies
Benzinga Insights
-
Oct 24, 2023, 11:00AM
Morgan Stanley Maintains Equal-Weight on Adaptive Biotechnologies, Lowers Price Target to $10
Benzinga Newsdesk
-
Oct 24, 2023, 8:20AM
Monday, October 16, 2023
Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Lowers Price Target to $13
Benzinga Newsdesk
-
Oct 16, 2023, 1:17PM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Tuesday, September 26, 2023
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Sep 26, 2023, 12:56PM
What's Going On With Adaptive Biotechnologies (ADPT) Stock?
Erica Kollmann
-
Sep 26, 2023, 11:39AM
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Sep 26, 2023, 10:49AM
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Sep 26, 2023, 8:05AM
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 21, 2023, 12:08PM
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 19, 2023, 12:50PM
Wednesday, September 13, 2023
Adaptive Announces Launch Of Epic Integration For clonoSEQ
Benzinga Newsdesk
-
Sep 13, 2023, 7:35AM
Tuesday, August 22, 2023
Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
Benzinga Neuro
-
Aug 22, 2023, 9:50PM
Monday, August 21, 2023
Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead
Benzinga Neuro
-
Aug 21, 2023, 10:27PM
Thursday, August 17, 2023
Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples
Benzinga Neuro
-
Aug 17, 2023, 10:04PM
Tuesday, August 15, 2023
Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company
Benzinga Neuro
-
Aug 15, 2023, 10:22PM
Monday, August 14, 2023
Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections
Benzinga Neuro
-
Aug 14, 2023, 10:18PM
Tuesday, August 08, 2023
Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Lowers Price Target to $14
Benzinga Newsdesk
-
Aug 8, 2023, 3:17PM
Friday, August 04, 2023
Morgan Stanley Maintains Equal-Weight on Adaptive Biotechnologies, Lowers Price Target to $13
Benzinga Newsdesk
-
Aug 4, 2023, 12:17PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch